Inventor
CROOKS PETER A
US54 patents
⚠️ This page may combine multiple inventors who share the name “CROOKS PETER A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV KENTUCKY RES FOUND
18 patentsUS5691365ANov 25, 1997
Nicotinic receptor antagonists in the treatment of neuropharmacological disorders
UNIV KENTUCKY RES FOUND52 citations95
US6087376AJul 11, 2000
Use of lobeline compounds in the treatment of central nervous system diseases and pathologies
UNIV KENTUCKY RES FOUND28 citations92
US5830904ANov 3, 1998
Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders
UNIV KENTUCKY RES FOUND24 citations92
US5681964AOct 28, 1997
Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
UNIV KENTUCKY RES FOUND79 citations92
US6765019B1Jul 20, 2004
Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
UNIV KENTUCKY RES FOUND16 citations91
US5552440ASep 3, 1996
Use of L-canavanine as a chemotherapeutic agent for the treatment of pancreatic cancer
UNIV KENTUCKY RES FOUND20 citations89
US6403602B1Jun 11, 2002
Morphine-6-sulfate analogues and their use for the treatment of pain
UNIV KENTUCKY RES FOUND18 citations76
US5776957AJul 7, 1998
Nornicotine enantiomers for use as a treatment for dopamine related conditions and disease states
UNIV KENTUCKY RES FOUND17 citations75
US6503922B2Jan 7, 2003
Bridged nicotine compounds for use in the treatment of CNS pathologies
UNIV KENTUCKY RES FOUND7 citations71
US6455543B1Sep 24, 2002
Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies
UNIV KENTUCKY RES FOUND6 citations71
US5859295AJan 12, 1999
Canavanine analogs and their use as chemotherapeutic agents
UNIV KENTUCKY RES FOUND7 citations70
US6218434B1Apr 17, 2001
Use of the naturally-occurring quinones thymoquinone and dithymoquinone as antineoplastic and cytotoxic agents
UNIV KENTUCKY RES FOUND13 citations68
US6943177B2Sep 13, 2005
Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies
UNIV KENTUCKY RES FOUND4 citations60
US7816407B2Oct 19, 2010
Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders
UNIV KENTUCKY RES FOUND4 citations55
US6703406B2Mar 9, 2004
2,6-disubstituted piperidines as modulators of nicotinic acetylcholine receptor mediated neurotransmitter release, uptake and storage
UNIV KENTUCKY RES FOUND5 citations55
US7091357B2Aug 15, 2006
Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies
UNIV KENTUCKY RES FOUND4 citations54
US7214710B2May 8, 2007
Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
UNIV KENTUCKY RES FOUND0 citations51
US8703803B2Apr 22, 2014
Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
UNIV KENTUCKY RES FOUND0 citations50
CROOKS PETER A
6 patentsUS8124652B2Feb 28, 2012
Use of parthenolide derivatives as antileukemic and cytotoxic agents
CROOKS PETER A12 citations91
US8470875B2Jun 25, 2013
Use of parthenolide derivatives as antileukemic and cytotoxic agents
CROOKS PETER A6 citations83
US7759358B2Jul 20, 2010
Oral bioavailable prodrugs
CROOKS PETER A11 citations78
US8884027B2Nov 11, 2014
Melampomagnolide B derivatives as antileukemic and cytotoxic agents
CROOKS PETER A7 citations77
US8101779B2Jan 24, 2012
Enantioselective synthesis of (+) and (–)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene
CROOKS PETER A2 citations53
US8629163B2Jan 14, 2014
Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors
CROOKS PETER A1 citations46
UNIV KENTUCKY
5 patentsUS7678904B2Mar 16, 2010
Use of parthenolide derivatives as antileukemic and cytotoxic agents
UNIV KENTUCKY24 citations92
US7312242B2Dec 25, 2007
Use of parthenolide derivatives as antileukemic and cytotoxic agents
UNIV KENTUCKY24 citations92
US7226949B2Jun 5, 2007
Compounds of use in the treatment of epilepsy, seizure, and electroconvulsive disorders
UNIV KENTUCKY20 citations84
US9045490B2Jun 2, 2015
Use of parthenolide derivatives as antileukemic and cytotoxic agents
UNIV KENTUCKY0 citations51
US8716329B2May 6, 2014
Use of parthenolide derivatives as antileukemic and cytotoxic agents
UNIV KENTUCKY0 citations51
ALONSO ROBERT
4 patentsUS8501819B2Aug 6, 2013
Stabilized compositions of volatile alkylating agents and methods of using thereof
ALONSO ROBERT1 citations60
US8450375B2May 28, 2013
Stabilized compositions of volatile alkylating agents and methods of using thereof
ALONSO ROBERT1 citations59
US8501817B2Aug 6, 2013
Stabilized compositions of alkylating agents and methods of using same
ALONSO ROBERT2 citations55
US8501818B2Aug 6, 2013
Stabilized compositions of alkylating agents and methods of using same
ALONSO ROBERT1 citations49
HOLTMAN JOSEPH R
3 patentsUS8710069B2Apr 29, 2014
Opioid-nornicotine codrugs combinations for pain management
HOLTMAN JOSEPH R10 citations78
US8710070B2Apr 29, 2014
Opioid-ketamine and norketamine codrug combinations for pain management
HOLTMAN JOSEPH R11 citations78
US9499518B2Nov 22, 2016
Bis-quaternary ammonium salts as pain modulating agents
HOLTMAN JOSEPH R0 citations46
TARGACEPT INC
2 patentsACTELION PHARMACEUTICALS LTD
2 patentsUNIV OF KENTUCKY
2 patentsYAUPON THERAPEUTICS INC
2 patentsJANGANATI VENUMADHAV
2 patentsSOUTHERN RES INST
1 patent(unassigned)
1 patentSTINCHCOMB AUDRA L
1 patentUNIV ARKANSAS
1 patentShowing the top 50 of 54 patents by PatentIndex Score.